medigraphic.com

2017, Number 4

<< Back Next >>

Rev Educ Bioquimica 2017; 36 (4)

La enzima glucógeno sintasa cinasa 3 regula la actividad de los factores de transcripción NF-kB y creb durante la respuesta inflamatoria causada por Staphylococcus aureus

Huante MA, Silva GO, Rico MR, Maldonado PMC, Baizabal AVM

Language: Spanish
References: 26
Page: 111-117
PDF size: 597.73 Kb.


ABSTRACT

The enzyme glycogen synthase kinase 3 (GSK3) is a Ser/Thr kinase that regulates the expression of cytokines during the inflammatory response by modulating the activity of nuclear factor kB (NF-kB) and cAMP response element-binding protein (CREB). This review presents one of the mechanisms that regulate GSK3 activity and its effect on Staphylococcus aureus infections


REFERENCES

  1. Gomperts BD, Kramer IM, Tatham PER (2003) Signal Transduction. Academic Press. Elsevier Science, Orlando, FL, USA.

  2. Medzhitov R, Preston-Hurlburt P, Janeway CA (1997) A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388: 394–397.

  3. Yang RB (1998) Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 395: 284–288.

  4. Dinarello CA (2000) Proinflammatory cytokines. Chest 118: 503–508.

  5. O’Neill LA, Dinarello CA (2000) The IL-1 receptor/Toll-like receptor superfamily: crucial receptors for inflammation and host defense. Immunol Today 21: 206–209.

  6. Jope RS, Johnson G (2004) The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci 29: 95-102.

  7. Martin M, Rehani K, Jope RS, Michalek SM (2005) Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat Immunol 6: 777-784.

  8. Lawrence T, Fong C (2010) The resolution of inflammation: anti-inflammatory roles for NFkappaB. Int J Biochem Cell Biol 42: 519–523.

  9. Steinke JW, Borish L (2006) Cytokines and chemokines. J Allergy Clin Immunol 117: S441–S445.

  10. Lawrence T, Gilroy DW (2007) Chronic inflammation: a failure of resolution? Int J Exp Pathol 88: 85–94.

  11. Commins SP, Borish L, Steinke JW (2010) Immunologic messenger molecules: cytokines, interferons, and chemokines. J Allergy Clin Immunol 125: 53–S72.

  12. Embi N, Rylatt DB, Cohen P (1980) Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur J Biochem 107: 519–527.

  13. Cortés-Vieyra R, Bravo-Patiño A, Valdez- Alarcón JJ, Cajero-Juárez M, Finlay BB, Baizabal-Aguirre VM (2012) Role of glycogen synthase kinase-3 beta in the inflammatory response caused by bacterial pathogens. J Inflamm (Lond) 9: 23.

  14. Fresno-Vara JA, Casado E, de Castro J, Cejas P, Belda-Iniesta C, González-Barón M (2004) PI3K/AKT signaling pathway and cancer. Cancer Treat Rev 30: 193-204.

  15. Staal SP (1987) Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma. Proc Natl Acad Sci USA 84: 5034–5037.

  16. Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P, Hemmings BA (1996) Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J 15: 6541–6551.

  17. Ruse M, Knaus UG (2006) New players in TLRmediated innate immunity. Immunol Res 34: 33-48.

  18. Beurel E, Michalek SM, Jope RS (2009) Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3).Trends Immunol 31: 24-31.

  19. Chan MM, Cheung BK, Li JC, Chan LL, Lau AS (2009) A role for glycogen synthase kinase-3 in antagonizing mycobacterial immune evasion by negatively regulating IL-10 induction. J Leukoc Biol 86: 283-291.

  20. Hirschfeld M, Weis JJ, Toshchakov V, Salkowski CA, Cody MJ, Ward DC, Quresshi N, Michalek SM, Vogel SN (2001) Signaling by Toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect Immun 69: 1477–1482.

  21. Pulendran B, Kumar P, Cutler CW, Mohamadzadeh M, Van Dyke T, Banchereau J (2001) Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo. J Immunol 167: 5067– 5076.

  22. Oviedo-Boyso J, Valdez-Alarcón JJ, Cajero- Juárez M, Ochoa-Zarzosa A, López-Meza JE, Bravo-Patiño A, Baizabal-Aguirre VM (2007) Innate immune response of bovine mammary gland to pathogenic bacteria responsible for mastitis. J Infect 54: 399-409.

  23. Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4: 499-511.

  24. Oviedo-Boyso J, Cortés-Vieyra R, Huante- Mendoza A, Yu HB, Valdez-Alarcón JJ, Bravo- Patiño A, Cajero-Juárez M, Finlay BB, Baizabal Aguirre VM (2011) The phosphoinositide-3- kinase-Akt signaling pathway is important for Staphylococcus aureus internalization by endothelial cells. Infect Immun 79: 4569–4577.

  25. Cortés-Vieyra R, Silva-García O, Oviedo-Boyso J, Huante Mendoza A, Bravo-Patiño A, Valdez- Alarcón JJ, Finlay BB, Baizabal-Aguirre VM (2015) The glycogen synthase kinase 325. Cortés-Vieyra R, Silva-García O, Oviedo- Boyso J, Huante Mendoza A, Bravo-Patiño A, Valdez-Alarcón JJ, Finlay BB, Baizabal- Aguirre VM (2015) The glycogen synthase kinase 3α and b isoforms differentially regulates interleukin12p40 expression in endothelial cells stimulated with peptidoglycan from Staphylococcus aureus. PLoS ONE 10(7): e0132867. doi:10.1371/journal. pone.0132867.

  26. Watford WT, Moriguchi M, Morinobu A, O’Shea JJ 2003 The biology of IL-12: coordinating innate and adaptive immune responses. Cytokine Growth Factor Rev 14: 361–368.




2020     |     www.medigraphic.com